Lupus

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Google Scholar
Right arrow Articles by Petri, M
Right arrow Articles by Buyon, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petri, M
Right arrow Articles by Buyon, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Lupus, Vol. 17, No. 8, 708-710 (2008)
DOI: 10.1177/0961203308092518

editorial

Editorial: Oral contraceptives in systemic lupus erythematosus: the case for (and against)

M Petri

Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, mpetri{at}jhmi.edu

JP Buyon

Division of Rheumatology, New York University School of Medicine, NYU Medical Centre, New York 10016

References

  • 1 Julkunen HA . Oral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE . Scand J Rheumatol 1991; 20: 427 – 433 .[ISI][Medline] [Order article via Infotrieve]
  • 2 Todd GR McAteer EJ Jack CM Maire M Roberts SD Buchanan KD . Pulmonary hypertension, systemic lupus erythematosus, and the contraceptive pill . Ann Rheum Dis 1985; 44: 266 – 267 .[Abstract/Free Full Text]
  • 3 Julkunen H Kaaja R Jouhikainen T Teppo AM Friman C . Malignant hypertension and antiphospholipid antibodies as presenting features of SLE in a young woman using oral contraceptives . Br J Rheumatol 1991; 30: 471 – 472 .[Abstract/Free Full Text]
  • 4 Travers RL Hughes GRV . Oral contraceptive therapy and systemic lupus erythematosus . J Rheumatol 1978; 5: 448 – 451 .[ISI][Medline] [Order article via Infotrieve]
  • 5 Garovich M Agudelo C Pisko E . Oral contraceptives and systemic lupus erythematosus . Arthritis Rheum 1980; 23: 1396 – 1398 .[ISI][Medline] [Order article via Infotrieve]
  • 6 Miller MH . Pulmonary hypertension, systemic lupus erythematosus, and the contraceptive pill: another report . Ann Rheum Dis 1987; 46: 159 – 161 .[Abstract/Free Full Text]
  • 7 Pimstone B . Systemic lupus erythematosus exacerbated by oral contraceptives . S Afr J Obstet Gynaecol 1966; 3: 62 – 63 .[Medline] [Order article via Infotrieve]
  • 8 Hadida M Sayag J . Lupus erythemateus subanu apparu apres une cure du Norfutin chez une malade atteinte de lupus erythematreux chronique . Soc Franc Derm Syph Bull 1968; 74: 616 – 621 .
  • 9 Chapel TA Burns RE . Oral contraceptives and exacerbation of lupus erythematosus . Am J Obstet Gynecol 1971; 110: 366 – 369 .[ISI][Medline] [Order article via Infotrieve]
  • 10 Laugier P Orusco P Chatelanat F Humair L Posternak S . Lupus érythémateux disseminé induit par estrogénes . Bull Soc Fr Dermatol Syphiligr 1971; 78: 623 – 628 .[Medline] [Order article via Infotrieve]
  • 11 Jungers P Dougados M Pelissier C . Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 618 – 623 .[ISI][Medline] [Order article via Infotrieve]
  • 12 Sanchez-Guerrero J Karlson EW Liang MH Hunter DJ Speizer FE Colditz GA . Past use of oral contraceptives and the risk of developing systemic lupus erythematosus . Arthritis Rheum 1997; 40: 804 – 808 .[Medline] [Order article via Infotrieve]
  • 13 Costenbader KH Feskanich D Stampfer MJ Karlson EW . Reproductive and menopausal factors and risk of systemic lupus erythematosus in women . Arthritis Rheum 2007; 56: 1251 – 1262 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • 14 Manson JE Hsia J Johnson KC . Estrogen plus progestin and the risk of coronary heart disease . N Engl J Med 2003; 349: 523 – 534 .[Abstract/Free Full Text]
  • 15 Petri M Kim MY Kalunian KC . Combined oral contraceptives in women with systemic lupus erythematosus . N Engl J Med 2005; 353: 2550 – 2558 .[Abstract/Free Full Text]
  • 16 Sanchez-Guerrero J Uribe AG Jimenez-Santana L . A trial of contraceptive methods in women with systemic lupus erythematosus . N Engl J Med 2005; 353: 2539 – 2549 .[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Google Scholar
Right arrow Articles by Petri, M
Right arrow Articles by Buyon, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petri, M
Right arrow Articles by Buyon, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?